There may be no field in which microfluidics is having a greater impact than in the world of medicine. The use of microfluidics organ-on-a-chip technology is revolutionizing the way we study human physiology, as well as in the methods in which we develop new drugs. These miniaturized, functional in vitro constructs aim to summarize the in vivo physiology of an organ using microfluidic chips. Through this technology’s ability to precisely control the cellular microenvironment, organ-on-a-chip devices can provide valuable insights into cell biology and lay the foundation for replicating the functions of human tissues and organs [1].
What is a Microfluidic Chip?
A microfluidic chip, also known as a lab-on-a-chip, is a device that manipulates small amounts of fluids (microliters to picoliters) using channels with dimensions ranging from tens to hundreds of micrometers [2]. These dimensions are at the same scale as biological cells or small tissue constructs, allowing researchers to precisely control and analyze them under optimal culturing conditions [3].
How are Microfluidic Chips Made?
Microfluidic chips are typically fabricated using a variety of materials, such as polydimethylsiloxane (PDMS), glass, and polymers [4]. The most common fabrication method involves soft lithography, where a master mold is created using photolithography, and PDMS is poured into the mold and cured [5]. This method creates a PDMS replica, which is then peeled off, and then access ports are punched to create inlets and outlets for the microfluidic channels [6].
How Do Microfluidic Chips Work?
Microfluidic chips work by precisely controlling the flow of fluids through its microchannel network. This flow is achieved by using external pumps or integrated micropumps and valves [7]. The small dimensions of the channels allow for laminar flow. This, in turn, enables the manipulation of cells and tissues with high precision [8]. Additionally, the microfluidic environment provides a more physiologically relevant culture system compared to traditional cell culture methods [9].
Related: Microfluidics Lab on a Chip
Organ-on-a-Chip Models
Various organ-on-a-chip models have been developed to study specific tissues and organs, including:
Heart-on-a-Chip
Heart-on-a-chip models incorporate cardiac cells and mimic the function of the heart. These devices can be used to study cardiac physiology, drug toxicity, and disease modeling [10].
Liver-on-a-Chip
Liver-on-a-chip models incorporate hepatocytes and other liver-specific cells to study liver function, drug metabolism, and toxicity. These devices can be used to predict potential hazards such as drug-induced liver injury, as well as develop personalized treatments [11].
Gut-on-a-Chip
Gut-on-a-chip models incorporate intestinal epithelial cells and mirror the dynamic mechanical forces of the intestine. These devices can be used to study intestinal physiology, assess host-microbiome interactions, and identify conditions such as inflammatory bowel diseases [12].
Bone-on-a-Chip
Bone-on-a-chip models incorporate bone cells and mimic the bone marrow microenvironment. These devices can be used to study the progress of bone regeneration, hematopoiesis, and metastatic cancer [13].
Also Check Out: Microfluidics: Revolutionizing Cell Culture
Applications of Microfluidics Organ-on-a-Chip in Cancer Research
Organ-on-a-chip technology has the significant potential to greatly impact cancer research, as it allows for the study of tumor-microenvironment interactions, and can be used in the development of personalized cancer treatments. By incorporating patient-derived tumor cells and the relevant organ-specific microenvironment, organ-on-a-chip models can be used to test drug efficacy and identify relevant biomarkers for patient stratification [14].
Challenges and Future Opportunities
While organ-on-a-chip technology holds great promise, it is not without its challenges, as there remains a need for improved cell sources, better integration of supporting technologies (e.g., biosensors, multi-electrode arrays), and the development of standardized protocols for device fabrication and data analysis [15].
In addition, the transition from academia to industry requires a focus on operational robustness and reproducibility [16].However, despite these issues, the future of microfluidics organ-on-a-chip technology is extremely bright. As the field continues to advance, we can expect to see more sophisticated multi-organ systems that better mimic human physiology. These systems have the potential to completely alter drug discovery, personalized medicine, and our understanding of human health and disease [17].
